SAM ZAND: Open Payments
NPI 1528485570 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$59,316 in 61 payments from 4 companies in 2025. Trend: 2023 $83,820 · 2024 $51,135 · 2025 $59,316
Speaker / faculty: $34,345Honoraria: $16,475Travel & lodging: $6,677Food & beverage: $1,818
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 40 | $40,955 |
| Axsome Therapeutics, Inc. | 17 | $18,057 |
| E.R. Squibb & Sons, L.L.C. | 3 | $182 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
Products named: SPRAVATO, Auvelity, COBENFY, REXULTI.
Industry payments across NV — which companies pay providers there.
